Technology ID

Anti-Vaccinia Monoclonal Antibody

Yewdell, Jonathan (Jon)
Research Materials
Therapeutic Areas
Infectious Disease
The current technology describes a monoclonal antibody that reacts with a vaccinia virus protein abundantly expressed under an early viral promoter after infection of cells. The antibody is useful for quantitating vaccinia virus infected cells and for studying the function of the protein to which it binds, which is known to be a double stranded RNA binding protein involved in resistance of the virus to interferons. This antibody is available for licensing through a biological materials license agreement.
Licensing Contact:
Hurley, Benjamin
Phone: +1 240 276 5489